NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

A. B. Benson; Thomas A. Abrams; Edgar Ben-Josef; P. Mark Bloomston; Jean F. Botha; Bryan M. Clary; Anne Covey; Steven A. Curley; Michael I. D'Angelica; Rene Davila; William D. Ensminger; John F. Gibbs; Daniel Laheru; Mokenge P. Malafa; Jorge Marrero; Steven G. Meranze; Sean J. Mulvihill; James O. Park; James A. Posey; Jasgit Sachdev; Riad Salem; Elin R. Sigurdson; Constantinos Sofocleous; Jean Nicolas Vauthey; Alan P. Venook; Laura Williams Goff; Yun Yen; Andrew X. Zhu

doi:10.6004/jnccn.2009.0027

NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

A. B. Benson
, Thomas A. Abrams
, Edgar Ben-Josef
, P. Mark Bloomston
, Jean F. Botha
, Bryan M. Clary
, Anne Covey
, Steven A. Curley
, Michael I. D'Angelica
, Rene Davila
, William D. Ensminger
, John F. Gibbs
, Daniel Laheru
, Mokenge P. Malafa
, Jorge Marrero
, Steven G. Meranze
, Sean J. Mulvihill
, James O. Park
, James A. Posey
, Jasgit Sachdev

Riad Salem, Elin R. Sigurdson, Constantinos Sofocleous, Jean Nicolas Vauthey, Alan P. Venook, Laura Williams Goff, Yun Yen, Andrew X. Zhu

Northwestern University

Research output: Contribution to journal › Review article › peer-review

411 Scopus citations

Abstract

Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.

Original language	English
Pages (from-to)	350-391
Number of pages	42
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	7
Issue number	4
DOIs	https://doi.org/10.6004/jnccn.2009.0027 https://doi.org/10.6004/jnccn.2009.0027
State	Published - Apr 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Biologic therapy
Chemoembolization
Chemotherapy
Cholangiocarcinomas
Cirrhosis
Gallbladder cancer
Hepatitis
Hepatocellular carcinoma
NCCN Clinical practice Guidelines
Surgical resection
Transplantation
Tumor ablation

Access to Document

Cite this

Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., Ensminger, W. D., Gibbs, J. F., Laheru, D., Malafa, M. P., Marrero, J., Meranze, S. G., Mulvihill, S. J., Park, J. O., Posey, J. A., ... Zhu, A. X. (2009). NCCN clinical practice guidelines in oncology: hepatobiliary cancers. Journal of the National Comprehensive Cancer Network : JNCCN, 7(4), 350-391. https://doi.org/10.6004/jnccn.2009.0027, https://doi.org/10.6004/jnccn.2009.0027

@article{85e84b1851a64bd68e34d924b828d29b,

title = "NCCN clinical practice guidelines in oncology: hepatobiliary cancers.",

abstract = "Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.",

keywords = "Biologic therapy, Chemoembolization, Chemotherapy, Cholangiocarcinomas, Cirrhosis, Gallbladder cancer, Hepatitis, Hepatocellular carcinoma, NCCN Clinical practice Guidelines, Surgical resection, Transplantation, Tumor ablation",

author = "Benson, \{A. B.\} and Abrams, \{Thomas A.\} and Edgar Ben-Josef and Bloomston, \{P. Mark\} and Botha, \{Jean F.\} and Clary, \{Bryan M.\} and Anne Covey and Curley, \{Steven A.\} and D'Angelica, \{Michael I.\} and Rene Davila and Ensminger, \{William D.\} and Gibbs, \{John F.\} and Daniel Laheru and Malafa, \{Mokenge P.\} and Jorge Marrero and Meranze, \{Steven G.\} and Mulvihill, \{Sean J.\} and Park, \{James O.\} and Posey, \{James A.\} and Jasgit Sachdev and Riad Salem and Sigurdson, \{Elin R.\} and Constantinos Sofocleous and Vauthey, \{Jean Nicolas\} and Venook, \{Alan P.\} and Goff, \{Laura Williams\} and Yun Yen and Zhu, \{Andrew X.\}",

year = "2009",

month = apr,

doi = "10.6004/jnccn.2009.0027",

language = "English",

volume = "7",

pages = "350--391",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Harborside Press",

number = "4",

}

Benson, AB, Abrams, TA, Ben-Josef, E, Bloomston, PM, Botha, JF, Clary, BM, Covey, A, Curley, SA, D'Angelica, MI, Davila, R, Ensminger, WD, Gibbs, JF, Laheru, D, Malafa, MP, Marrero, J, Meranze, SG, Mulvihill, SJ, Park, JO, Posey, JA, Sachdev, J, Salem, R, Sigurdson, ER, Sofocleous, C, Vauthey, JN, Venook, AP, Goff, LW, Yen, Y & Zhu, AX 2009, 'NCCN clinical practice guidelines in oncology: hepatobiliary cancers.', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 7, no. 4, pp. 350-391. https://doi.org/10.6004/jnccn.2009.0027, https://doi.org/10.6004/jnccn.2009.0027

TY - JOUR

T1 - NCCN clinical practice guidelines in oncology

T2 - hepatobiliary cancers.

AU - Benson, A. B.

AU - Abrams, Thomas A.

AU - Ben-Josef, Edgar

AU - Bloomston, P. Mark

AU - Botha, Jean F.

AU - Clary, Bryan M.

AU - Covey, Anne

AU - Curley, Steven A.

AU - D'Angelica, Michael I.

AU - Davila, Rene

AU - Ensminger, William D.

AU - Gibbs, John F.

AU - Laheru, Daniel

AU - Malafa, Mokenge P.

AU - Marrero, Jorge

AU - Meranze, Steven G.

AU - Mulvihill, Sean J.

AU - Park, James O.

AU - Posey, James A.

AU - Sachdev, Jasgit

AU - Salem, Riad

AU - Sigurdson, Elin R.

AU - Sofocleous, Constantinos

AU - Vauthey, Jean Nicolas

AU - Venook, Alan P.

AU - Goff, Laura Williams

AU - Yen, Yun

AU - Zhu, Andrew X.

PY - 2009/4

Y1 - 2009/4

N2 - Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.

AB - Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.

KW - Biologic therapy

KW - Chemoembolization

KW - Chemotherapy

KW - Cholangiocarcinomas

KW - Cirrhosis

KW - Gallbladder cancer

KW - Hepatitis

KW - Hepatocellular carcinoma

KW - NCCN Clinical practice Guidelines

KW - Surgical resection

KW - Transplantation

KW - Tumor ablation

UR - https://www.scopus.com/pages/publications/67649992397

U2 - 10.6004/jnccn.2009.0027

DO - 10.6004/jnccn.2009.0027

M3 - Review article

C2 - 19406039

AN - SCOPUS:67649992397

SN - 1540-1405

VL - 7

SP - 350

EP - 391

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 4

ER -

NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this